Show simple item record

dc.contributor.advisorCelis Rodríguez, Edgar 
dc.contributor.advisorCarrizosa, Jorge Armando 
dc.creatorBeltran Gomez, Edwin 
dc.creatorAcevedo Bedoya, Camilo 
dc.creatorLeal, lucia 
dc.creatorGuevara Pulido, Fredy Orlando 
dc.creatorRodríguez Lima, David 
dc.date.accessioned2015-08-06T00:57:41Z
dc.date.available2015-08-06T00:57:41Z
dc.date.created2015-06-04
dc.date.issued2015 
dc.identifier.urihttp://repository.urosario.edu.co/handle/10336/10651
dc.descriptionSe realizó un estudio descriptivo, retrospectivo; se usó la base de datos de los aislamientos microbiológicos documentados en las UCI de la Fundación Santa fe de Bogotá para el año 2014. La prevalencia de bacterias resistentes en los aislamientos de la FSFB no es baja, por lo que se requiere una terapia empírica acertada acorde con la flora local. Se requieren estudios analíticos para evaluar factores asociados al desarrollo de gérmenes multi resistentes y mortalidad por sepsis
dc.description.abstractThe incidence of bacteremia was 39%, the diagnosis of sepsis, severe sepsis and septic shock was overall from 50%, the most frequently isolated microorganisms were gram negative bacteria (44, 5%), followed by Candida species (37.5%) and gram negative (18%). 91% of patients received antibiotic therapy empirically, and this management strategy was adjusted with culture results in 57% of cases, most of these received combination therapy (63%). The empirical use of carbapenems was 36%, while that of cephalosporins third and fourth generation was 14.8%. Different resistance patterns usual were found in 31% of the isolates, mainly AmpC (17.6%) and ESBL (12%). ICU mortality was 30%.
dc.format.mimetypeapplication/pdf
dc.language.isospa
dc.rights.urihttp://creativecommons.org/licenses/by-nd/2.5/co/
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.subjectDrug Resistance
dc.subjectIntensive care
dc.subjectMicrobial sensivity tests
dc.subjectEpidemiological Monitoring
dc.subjectSepsis
dc.subject.ddcFarmacología & terapéutica 
dc.titlePerfil de resistencia microbiológico en ciudados intensivos adultos en la fundación Santa Fe de Bogotá año 2014
dc.typebachelorThesis
dc.publisherUniversidad del Rosario
dc.creator.degreeEspecialista en Medicina Crítica y Cuidado Intensivo
dc.publisher.programEspecialización en Medicina Crítica y Cuidado Intensivo
dc.publisher.departmentFacultad de Medicina
dc.subject.keywordDrug Resistance
dc.subject.keywordIntensive care
dc.subject.keywordSensivity microbial tests
dc.subject.keywordEpidemiological Monitoring
dc.subject.keywordSepsis
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.subject.decsResistencia medicamentos
dc.subject.decsInfección hospitalaria
dc.subject.decsCuidados intensivos
dc.subject.decsMonitoreo epidemiológico
dc.subject.decsAgentes antibacterianos
dc.type.spaTrabajo de grado
dc.rights.accesoAbierto (Texto completo)
dc.type.hasVersioninfo:eu-repo/semantics/acceptedVersion
dc.source.bibliographicCitationKlevens RM, Edwards JR, Richards CL, Horan TC, Gaynes RP, Pollock DA, et al. Estimating health care-associated infections and deaths in US hospitals, 2002. Public health reports 2007;122(2):160.
dc.source.bibliographicCitationKarlsson S, Varpula M, Ruokonen E, Pettil+ñ V, Parviainen I, Ala-Kokko TI, et al. Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: the Finnsepsis study. Intensive care medicine 2007;33(3):435-43
dc.source.bibliographicCitationZahorec R, Firment J, Strakova J, Mikula J, Malik P, Novak I, et al. Epidemiology of severe sepsis in intensive care units in the Slovak Republic. Infection 2005;33(3):122-8
dc.source.bibliographicCitationInfectious Diseases Society of America. Bad Bugs, No Drugs: As Antibiotic Discovery Stagnates--a Public Health Crisis Brews. 2004.
dc.source.bibliographicCitationNational Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. American journal of infection control 2004;32(8):470
dc.source.bibliographicCitationStyers D, Sheehan DJ, Hogan P, Sahm DF. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Annals of clinical microbiology and antimicrobials 2006;5(1):2.
dc.source.bibliographicCitationHuang SS, Rifas-Shiman SL, Warren DK, Fraser VJ, Climo MW, Wong ES, et al. Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units. Journal of Infectious Diseases 2007;195(3):330-8
dc.source.bibliographicCitationLockhart SR, Abramson MA, Beekmann SE, Gallagher G, Riedel S, Diekema DJ, et al. Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. Journal of clinical microbiology 2007;45(10):3352-9.
dc.source.bibliographicCitationGoossens H, Grabein B+. Prevalence and antimicrobial susceptibility data for extended-spectrum +¦-lactamaseGÇôand AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997GÇô2004). Diagnostic microbiology and infectious disease 2005;53(4):257-64
dc.source.bibliographicCitationGales AC, Jones RN, Forward KR, Linares J, Sader HS, Verhoef J. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997GÇô1999). Clinical Infectious Diseases 2001;32(Supplement 2):S104-S113
dc.source.bibliographicCitationWeinstein RA, Gaynes R, Edwards JR. Overview of nosocomial infections caused by gram-negative bacilli. Clinical Infectious Diseases 2005;41(6):848-54
dc.source.bibliographicCitationHindler JF, Stelling J. Analysis and presentation of cumulative antibiograms: a new consensus guideline from the Clinical and Laboratory Standards Institute. Clinical Infectious Diseases 2007;44(6):867-73.
dc.source.bibliographicCitationStratton CW, Ratner H, Johnston PE, Schaffner W. Focused microbiologic surveillance by specific hospital unit: practical application and clinical utility. Clinical therapeutics 1992;15:12-20.
dc.source.bibliographicCitationBinkley S, Fishman NO, LaRosa LA, Marr AM, Nachamkin I, Wordell D, et al. Comparison of Unit-Specific and Hospital-Wide Antibiograms Potential Implications for Selection of Empirical Antimicrobial Therapy. Infection Control 2006;27(07):682-7.
dc.source.bibliographicCitationAlberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive care medicine 2002;28(2):108-21.
dc.source.bibliographicCitationEngel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H, Grond S, et al. Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive care medicine 2007;33(4):606-18.
dc.source.bibliographicCitationSilva Ez, Pedro MA, Sogayar AC, Mohovic T, Silva CL, Janiszewski M, et al. Brazilian sepsis epidemiological study (BASES study). Critical Care 2004;8(4):R251.
dc.source.bibliographicCitationCheng B, Xie G, Yao S, Wu X, Guo Q, Gu M, et al. Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China*. Critical care medicine 2007;35(11):2538-46
dc.source.bibliographicCitationDegoricija V, Sharma M, Legac A, Gradi+íer M, +áefer S, Vu-ìi-ìevi-ç +e. Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy. Croatian medical journal 2006;47(3):385-97.
dc.source.bibliographicCitationMarkogiannakis H, Pachylaki N, Samara E, Kalderi M, Minettou M, Toutouza M, et al. Infections in a surgical intensive care unit of a university hospital in Greece. International Journal of Infectious Diseases 2009;13(2):145-53
dc.source.bibliographicCitationVincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al. Sepsis in European intensive care units: Results of the SOAP study*. Critical care medicine 2006;34(2):344-53.
dc.source.bibliographicCitationTanriover MD, Guven GS, Sen D, Unal S, Uzun O. Epidemiology and outcome of sepsis in a tertiary-care hospital in a developing country. Epidemiology and infection 2006;134(02):315-22.
dc.source.bibliographicCitationMolina FJ, D+¡az CA, Barrera L, De La Rosa G, Dennis R, Due+¦as C, et al. Perfil microbiol+¦gico de la Infecciones en Unidades de Cuidados Intensivos de Colombia (EPISEPSIS Colombia). Medicina Intensiva 2011;35(2):75-83.
dc.source.bibliographicCitationMart+¡nez Buitrago E, Hern+índez C, Pallares C, Pacheco R, Hurtado K, Recalde M+. Frecuencia de aislamientos microbiol+¦gicos y perfil de resistencia bacteriana en 13 cl+¡nicas y hospitales de alta complejidad en Santiago de Cali-Colombia. Infectio 2014;18(1):3-11.
dc.source.bibliographicCitationMateus JE, Le+¦n FJ, Gonz+ílez GM, Narv+íez EX. Resistencia a los antibi+¦ticos en dos unidades de cuidados intensivos de Bucaramanga (Colombia). Salud & Sociedad 2014;1(1).
dc.source.bibliographicCitationAppleby DH, John Jr JF. Use, misuse, and cost of parenteral cephalosporins at a county hospital. Southern medical journal 1980;73(11):1473-5.
dc.source.bibliographicCitationJogerst GJ, Dippe SE. Antibiotic use among medical specialties in a community hospital. Jama 1981;245(8):842-6
dc.source.bibliographicCitationCosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clinical Infectious Diseases 2003;36(1):53-9.
dc.source.bibliographicCitationSalgado CD, Farr BM. Outcomes associated with vancomycin-resistant enterococci: a meta-analysis. Infection Control 2003;24(09):690-8
dc.source.bibliographicCitationSong X, Srinivasan A, Plaut D, Perl TM. Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs. Infection Control 2003;24(04):251-6.
dc.source.bibliographicCitationDupont H, Mentec H, Sollet JP, Bleichner G. Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia. Intensive care medicine 2001;27(2):355-62.
dc.source.bibliographicCitationIregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. CHEST Journal 2002;122(1):262-8.
dc.source.bibliographicCitationLeone M, Bourgoin Al, Cambon S, Dubuc M, Alban+¿se J, Martin C. Empirical antimicrobial therapy of septic shock patients: Adequacy and impact on the outcome*. Critical care medicine 2003;31(2):462-7.
dc.source.bibliographicCitationGrupper M, Sprecher H, Mashiach T, Finkelstein R. Attributable mortality of nosocomial Acinetobacter bacteremia. Infection Control 2007;28(03):293-8.
dc.source.bibliographicCitationRello J, Gallego M, Mariscal D, Sonora R, Valles J. The value of routine microbial investigation in ventilator-associated pneumonia. American journal of respiratory and critical care medicine 1997;156(1):196-200
dc.source.bibliographicCitationKollef MH, Ward S. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. CHEST Journal 1998;113(2):412-20.
dc.source.bibliographicCitationSanchez-Nieto JM, Torres A, Garcia-Cordoba F, El-Ebiary M, Carrillo A, Ruiz J, et al. Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study. American journal of respiratory and critical care medicine 1998;157(2):371-6.
dc.source.bibliographicCitationAlvarez-Lerma F, ICU-acquired Pneumonia Study Group. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. Intensive care medicine 1996;22(5):387-94.
dc.source.bibliographicCitationCamargo R, Zuluaga I, Mar+¡n A, Salcedo S, Niebles J, Hern+índez M, et al. Valoraci+¦n diaria de la prescripci+¦n de antibi+¦ticos en una instituci+¦n de salud y su impacto en la resistencia a bacterias Gram negativas en cuidados intensivos. Acta Colombiana de Cuidado Intensivo 2008;8(4):293-301.
dc.rights.ccAtribución-SinDerivadas 2.5 Colombia
dc.rights.licenciaEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by-nd/2.5/co/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nd/2.5/co/